Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon bought 27 shares of the firm's stock in a transaction that occurred on Wednesday, October 16th. The shares were acquired at an average price of GBX 1,505 ($19.65) per share, with a total value of £406.35 ($530.62).
Liam Condon also recently made the following trade(s):
- On Wednesday, September 18th, Liam Condon acquired 21 shares of Johnson Matthey stock. The stock was purchased at an average price of GBX 1,598 ($20.87) per share, with a total value of £335.58 ($438.21).
Johnson Matthey Price Performance
JMAT stock traded up GBX 8 ($0.10) during midday trading on Thursday, reaching GBX 1,510 ($19.72). 401,966 shares of the company's stock traded hands, compared to its average volume of 973,779. The company has a 50-day simple moving average of GBX 1,563.48 and a two-hundred day simple moving average of GBX 1,667.28. Johnson Matthey PLC has a 1-year low of GBX 1,428.50 ($18.65) and a 1-year high of GBX 1,917.07 ($25.03). The company has a market cap of £2.63 billion, a price-to-earnings ratio of 2,603.45, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 63.15.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 2,400 ($31.34) target price on shares of Johnson Matthey in a report on Monday, June 24th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 1,993.33 ($26.03).
View Our Latest Research Report on Johnson Matthey
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.